Cargando…

A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells

BACKGROUND: Autoantibodies are a hallmark of autoimmune diseases. Autoantibody screening by indirect immunofluorescence staining of HEp-2 cells with patient sera is a current standard in clinical practice. Differential diagnosis of autoimmune disorders is based on commonly recognizable nuclear and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Julia Y., Zhang, Wei, Rho, Jung-hyun, Roehrl, Michael W., Roehrl, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507713/
https://www.ncbi.nlm.nih.gov/pubmed/32973414
http://dx.doi.org/10.1186/s12014-020-09298-3
_version_ 1783585284558946304
author Wang, Julia Y.
Zhang, Wei
Rho, Jung-hyun
Roehrl, Michael W.
Roehrl, Michael H.
author_facet Wang, Julia Y.
Zhang, Wei
Rho, Jung-hyun
Roehrl, Michael W.
Roehrl, Michael H.
author_sort Wang, Julia Y.
collection PubMed
description BACKGROUND: Autoantibodies are a hallmark of autoimmune diseases. Autoantibody screening by indirect immunofluorescence staining of HEp-2 cells with patient sera is a current standard in clinical practice. Differential diagnosis of autoimmune disorders is based on commonly recognizable nuclear and cytoplasmic staining patterns. In this study, we attempted to identify as many autoantigens as possible from HEp-2 cells using a unique proteomic DS-affinity enrichment strategy. METHODS: HEp-2 cells were cultured and lysed. Total proteins were extracted from cell lysate and fractionated with DS-Sepharose resins. Proteins were eluted with salt gradients, and fractions with low to high affinity were collected and sequenced by mass spectrometry. Literature text mining was conducted to verify the autoantigenicity of each protein. Protein interaction network and pathway analyses were performed on all identified proteins. RESULTS: This study identified 107 proteins from fractions with low to high DS-affinity. Of these, 78 are verified autoantigens with previous reports as targets of autoantibodies, whereas 29 might be potential autoantigens yet to be verified. Among the 107 proteins, 82 can be located to nucleus and 15 to the mitotic cell cycle, which may correspond to the dominance of nuclear and mitotic staining patterns in HEp-2 test. There are 55 vesicle-associated proteins and 12 ribonucleoprotein granule proteins, which may contribute to the diverse speckled patterns in HEp-2 stains. There are also 32 proteins related to the cytoskeleton. Protein network analysis indicates that these proteins have significantly more interactions among themselves than would be expected of a random set, with the top 3 networks being mRNA metabolic process regulation, apoptosis, and DNA conformation change. CONCLUSIONS: This study provides a proteomic repertoire of confirmed and potential autoantigens for future studies, and the findings are consistent with a mechanism for autoantigenicity: how self-molecules may form molecular complexes with DS to elicit autoimmunity. Our data contribute to the molecular etiology of autoimmunity and may deepen our understanding of autoimmune diseases.
format Online
Article
Text
id pubmed-7507713
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75077132020-09-23 A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells Wang, Julia Y. Zhang, Wei Rho, Jung-hyun Roehrl, Michael W. Roehrl, Michael H. Clin Proteomics Research BACKGROUND: Autoantibodies are a hallmark of autoimmune diseases. Autoantibody screening by indirect immunofluorescence staining of HEp-2 cells with patient sera is a current standard in clinical practice. Differential diagnosis of autoimmune disorders is based on commonly recognizable nuclear and cytoplasmic staining patterns. In this study, we attempted to identify as many autoantigens as possible from HEp-2 cells using a unique proteomic DS-affinity enrichment strategy. METHODS: HEp-2 cells were cultured and lysed. Total proteins were extracted from cell lysate and fractionated with DS-Sepharose resins. Proteins were eluted with salt gradients, and fractions with low to high affinity were collected and sequenced by mass spectrometry. Literature text mining was conducted to verify the autoantigenicity of each protein. Protein interaction network and pathway analyses were performed on all identified proteins. RESULTS: This study identified 107 proteins from fractions with low to high DS-affinity. Of these, 78 are verified autoantigens with previous reports as targets of autoantibodies, whereas 29 might be potential autoantigens yet to be verified. Among the 107 proteins, 82 can be located to nucleus and 15 to the mitotic cell cycle, which may correspond to the dominance of nuclear and mitotic staining patterns in HEp-2 test. There are 55 vesicle-associated proteins and 12 ribonucleoprotein granule proteins, which may contribute to the diverse speckled patterns in HEp-2 stains. There are also 32 proteins related to the cytoskeleton. Protein network analysis indicates that these proteins have significantly more interactions among themselves than would be expected of a random set, with the top 3 networks being mRNA metabolic process regulation, apoptosis, and DNA conformation change. CONCLUSIONS: This study provides a proteomic repertoire of confirmed and potential autoantigens for future studies, and the findings are consistent with a mechanism for autoantigenicity: how self-molecules may form molecular complexes with DS to elicit autoimmunity. Our data contribute to the molecular etiology of autoimmunity and may deepen our understanding of autoimmune diseases. BioMed Central 2020-09-21 /pmc/articles/PMC7507713/ /pubmed/32973414 http://dx.doi.org/10.1186/s12014-020-09298-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Julia Y.
Zhang, Wei
Rho, Jung-hyun
Roehrl, Michael W.
Roehrl, Michael H.
A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells
title A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells
title_full A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells
title_fullStr A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells
title_full_unstemmed A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells
title_short A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells
title_sort proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate hep-2 cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507713/
https://www.ncbi.nlm.nih.gov/pubmed/32973414
http://dx.doi.org/10.1186/s12014-020-09298-3
work_keys_str_mv AT wangjuliay aproteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells
AT zhangwei aproteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells
AT rhojunghyun aproteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells
AT roehrlmichaelw aproteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells
AT roehrlmichaelh aproteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells
AT wangjuliay proteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells
AT zhangwei proteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells
AT rhojunghyun proteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells
AT roehrlmichaelw proteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells
AT roehrlmichaelh proteomicrepertoireofautoantigensidentifiedfromtheclassicautoantibodyclinicaltestsubstratehep2cells